Identification and validation of poor prognosis immunoevasive subtype of muscle-invasive bladder cancer with tumor-infiltrating podoplanin(+) cell abundance

The choice of chemo- or immuno-therapy for muscle-invasive bladder cancer (MIBC) patients remains contentious. Podoplanin is newly identified as an immune checkpoint which intrigues us to explore the clinical significance and immunoregulatory role of tumor-infiltrating podoplanin(+) cells (PDPN(+) c...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Oncoimmunology
Autori principali: Zhou, Quan, Wang, Zewei, Zeng, Han, Zhang, Hongyu, Liu, Zhaopei, Huang, Qiuren, Wang, Jiajun, Chang, Yuan, Bai, Qi, Liu, Li, Zhu, Yu, Xu, Le, Dai, Bo, Guo, Jianming, Xia, Yu, Wang, Yiwei, Xu, Jiejie
Natura: Artigo
Lingua:Inglês
Pubblicazione: Taylor & Francis 2020
Soggetti:
Back Matter
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7759386/
https://ncbi.nlm.nih.gov/pubmed/33457092
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2020.1747333
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi